Biogen (BIIB) Gross Margin (2009 - 2026)
Biogen (BIIB) recorded Gross Margin of 73.31% in Q3 2026, down 0.08 percentage points from 73.39% a year earlier but up 1.71 percentage points from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Gross Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Biogen's Gross Margin came in at 73.96% as of Sep 30, 2026, down 1.28 percentage points year-over-year; for FY2025, it was 75.69%, down 0.43 percentage points from FY2024.
- Annual Gross Margin has a five-year change of -10.88 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 76.12% in FY2024 (+1.88 pp), 74.24% in FY2023 (-3.36 pp), 77.61% in FY2022 (-3.18 pp) and 80.79% in FY2021 (-5.78 pp).
- Quarterly Gross Margin has ranged from 70.22% in Q1 2022 to 81.31% in Q2 2022 over the past five years.
- On a year-over-year basis, Gross Margin has declined for three consecutive quarters, with an average year-over-year change of -0.73 percentage points over the last eight quarters.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 3.24 percentage points in Q1 2024, against a drop of 12.03 percentage points in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 71.60% (Q2 2026), 73.32% (Q1 2026) and 78.26% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 75.71% |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 73.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 73.31% |
| Jun 30, 2026 | 71.60% |
| Mar 31, 2026 | 73.32% |
| Dec 31, 2025 | 78.26% |
| Sep 30, 2025 | 73.39% |
| Jun 30, 2025 | 77.13% |
| Mar 31, 2025 | 74.11% |
| Dec 31, 2024 | 76.23% |
| Sep 30, 2024 | 74.10% |
| Jun 30, 2024 | 77.85% |
| Mar 31, 2024 | 76.33% |
| Dec 31, 2023 | 74.09% |
| Sep 30, 2023 | 73.93% |
| Jun 30, 2023 | 75.87% |
| Mar 31, 2023 | 73.09% |
| Dec 31, 2022 | 77.56% |
| Sep 30, 2022 | 81.28% |
| Jun 30, 2022 | 81.31% |
| Mar 31, 2022 | 70.22% |
| Dec 31, 2021 | 75.85% |
API Access
Biogen Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();